A carregar...
Effects of the Histone Deacetylase Inhibitor ITF2357 in Autoinflammatory Syndromes
We explored the effects of the oral histone deacetylase (HDAC) inhibitor ITF2357 in patients with autoinflammatory syndrome. In this prospective open-label pilot study, eight patients were enrolled; one patient with tumor necrosis factor receptor–associated periodic syndrome (TRAPS), three patients...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
ScholarOne
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3105134/ https://ncbi.nlm.nih.gov/pubmed/21274502 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2011.00039 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|